Abbvie’s RINVOQ® (upadacitinib) Approved by U.S. FDA as an Oral Treatment for Adults with Active Ankylosing Spondylitis
May 4, 2022 | BioForward Member News
Events
June 2023
Jun 05 - 08 2023
BIO International Convention
Boston Convention & Exhibition Center
Jun 05 - 09 2023
2023 Morgridge Entrepreneurial Bootcamp
Jun 20 - 22 2023
NIH SBIR/STTR Proposal Workshop
Jun 27 - 29 2023
Summerfest Tech 2023
Potawatomi Hotel & Casino
July 2023
Jul 22 2023
2023 Unity Picnic
October 2023
Oct 10 2023
Wisconsin Innovation Awards
Oct 17 2023
Wisconsin Biohealth Summit
Overture Center for the Arts
December 2023
Dec 12 2023
2023 End of Year Celebration
No event found!